{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:pegmolesatide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:amilomotide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:marzeptacog alfa (activated) [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:eptacog alfa pegol (activated) [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
JAN:VATREPTACOG ALFA (ACTIVATED) [JAN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Ilatreotide was developed as a somatostatin receptor agonist with potential for treating gastroenteropancreatic tumors. It is an orally active pituitary and guts hormonal secretion inhibitor.
Status:
Designated
Source:
FDA ORPHAN DRUG:782420
Source URL:
Class:
PROTEIN
